Euc Klinika Ostrava a.s.
- Address
- lock Available on a paid plan
EUC Klinika Ostrava - Respiratory Research Center
EUC Klinika Ostrava a.s. is a specialized medical research facility focusing on respiratory diseases, with particular expertise in chronic obstructive pulmonary disease (COPD) and advanced therapeutic interventions. The center conducts clinical trials evaluating novel biologic therapies for patients with moderate to very severe respiratory conditions.
- Chronic Obstructive Pulmonary Disease (COPD) with frequent exacerbations
- Biologic therapies targeting eosinophilic inflammatory pathways
- Advanced respiratory disease management and exacerbation prevention
The research center specializes in studying patients with elevated peripheral blood eosinophils and focuses on reducing COPD exacerbations through targeted interventions. Their clinical trial portfolio includes evaluation of benralizumab and other innovative treatments designed to improve outcomes for patients with severe respiratory disease and history of frequent acute exacerbations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Euc Klinika Ostrava a.s.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Benralizumab in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease with Frequent Exacerbations | AstraZeneca AB | Phase III | Not Recruiting | Nov 2019 | Jul 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Benralizumab | 1 | Unknown | 2019-11-12 | 2019-11-12 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.